Domainex's newsletter brings you up to speed on the latest announcements from the team.
No images? Click here
Domainex newsletter
All the latest news and industry insights from the Domainex team
Tom Mander, CEO
International and UK growth lead to exciting expansion plans for Domainex
We kicked off the spring with the announcement that we’d received a King’s Award for Enterprise: International Trade 2023, which recognised the company’s outstanding growth in international trade over three years with more than 100% increase in international revenues during the period. As always, it was a fantastic way to recognise all the team’s hard work and motivates us all to continue working hard to enrich our clients’ medicines pipelines.
Just over 18 months ago, we opened a new facility at Unity Campus to provide a dedicated Biology facility and to also free up space at Chesterford Research Park for our Chemistry and Bioanalytical departments. Since then, our team has significantly expanded and we are thrilled to have signed a new lease at Unity Campus to more than triple our space there. This new facility will provide space for both new instrumentation and team members, with capacity for over 100 biologists. This additional capacity will be essential for us to continue on our rapid, organic growth trajectory and to expand the range of biological services we can offer. We invite you to suggest new services that you would like to see us introduce to support you research projects needs.
As always, I am grateful to our shareholders for their continued support for our growth and I am proud of all my colleagues; without their hard work and dedication, we would not be in this exciting position. And thank you to all our clients, old and new for continuing to bring exciting projects our way – we look forward to working with you as we continue to grow.
We are honoured to have received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises our outstanding growth in international trade over three years. We are also finalists in this year’s Cambridge Independent SME Cambridgeshire Business Awards in three categories: High Growth Business of the Year, Employer of the Year, and Business of the Year more than 50 Employees.
Domainex expands its research operations by securing from Howard Group a new facility at Unity Campus
Following an exceptional period of growth, we’re thrilled to announce that we’ve signed a new lease at Unity Campus, expanding our facility there to house our growing team. Read more.
Domainex launches new Cryo-EM and Flow Cytometry services
We're pleased to launch our Cryogenic Electron Microscopy and Flow Cytometry services to expand our offering. Our experienced team of scientists would love to discuss these techniques with you and how they can advance your project.
Domainex opens offices in Cambridge, MA
Our home has always been Cambridge, UK and the surrounding area, so Cambridge, MA seemed like the perfect location to open our new US office. Please get in touch if you’re in the area and looking for a new drug discovery partner.
Domainex expands biophysical capabilities with purchase of new equipment from Malvern Panalytical
We have purchased an additional WAVEdelta system and a MicroCal PEAQ-ITC from Malvern Panalytical. This will enable us to support even more clients and will ensure we can maintain a rapid turnaround of high-quality data.
New recruits
Welcome to the Domainex team to William Lee, Eleftheria Arvaniti, Elliot Davenport, Emma Alexander, Lubana Anjum, Alicja Kazmierska and Amy Dunn. Visit our website to view the current available opportunities and find out more about working at Domainex.
Upcoming events
AI in Chemistry 2023
4th-5th September 2023 | Cambridge, UK
SCI / RSC 22nd Medicinal Chemistry Symposium
10th-13th September 2023 | Cambridge, UK
Discovery on Target
25th-28th September 2023 | Boston, MA, USA
Postgraduate Symposium XVII – Biological and Medicinal Chemistry Symposium for Postgraduates 2023
7th December 2023 | Oxford, UK
